Skip to content

Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese

Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01453972
Acronym
TRENO
Enrollment
30
Registered
2011-10-18
Start date
2011-10-31
Completion date
2012-12-31
Last updated
2016-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

Exercise, High-intensity, Interval training

Brief summary

The main purpose of our study is to examine the physiological adaptations in oxygen transport chain for high-intensity exercise and moderate exercise in overweight and obese humans. The main goals are: 1. To investigate the most effective short-and long-interval training in terms of VO2max, pulmonary diffusion, cardiac output, endothelial function and mitochondrial function. 2. How these physiological adaptations affect the aerobic endurance and performance, and how this training can reduce the risk of cardiovascular diseases related to overweight and obesity.

Interventions

BEHAVIORALLong distanse moderate training

Moderate exercise

BEHAVIORALLong interval training

High-intensity exercise, long duration

BEHAVIORALShort interval training

High intensity exercise, short duration

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \> 25

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Maximal oxygen uptake6 weeksChange in maximal oxygen uptake will be measured after six weeks of various exercise training and related to changes in blood volume, cardiac function, endothelial function and mitochondrial function.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026